Roche CT-388 Obesity Drug Posts 22.5% Weight Loss
Roche CT-388 Obesity Drug shows up to 22.5% placebo-adjusted weight loss at 48 weeks, as Roche moves into Phase 3 to challenge Lilly and Novo.
AI in Drug Development helps Pharma Cut Trial Admin Time
AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.
HIV ARV Tender Crisis Triggers Parliamentary Scrutiny
South Africa faces an HIV ARV tender crisis as major suppliers enter business rescue, risking vital medicine availability.
WhatsApp Microlearning: Solving a Persistent HIV Training Gap
WhatsApp Microlearning helps clinics deliver quick, practical HIV policy updates, improving guideline uptake and service delivery.
Gauteng Health Budget Underspending Exposes Service Pressure
Gauteng Health Budget Underspending could return R463.5m to the fiscus, despite crumbling hospitals, vacancies and equipment shortages.
Busa Seeks an NHI Meeting with President Ramaphosa
Business Unity South Africa (Busa) has backed Finance Minister Enoch Godongwana’s call to cool tensions around National Health Insurance.